NeurologyLive® Staff

Look back on some of our most popular video interviews with experts in the field, including discussions on stroke, migraine, Parkinson disease, dementia, and more.

The approvals introduced several new agents into a number of patient populations, including much-needed additions to some diseases lacking a large number of options.

Catch up on some of our most popular Peer Exchange panels with experts in the field, including discussions on epilepsy, migraine, multiple sclerosis, and more.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending December 26, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending December 25, 2020.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending December 19, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending December 18, 2020.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending December 12, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending December 11, 2020.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending December 5, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending December 4, 2020.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending November 28, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 27, 2020.

A University of Miami Miller School of Medicine neuroscientist and molecular biologist is leading a collaborative study that could develop new insights into how cellular processes affect neurodegenerative diseases.

Mayo Clinic's section edition book helps patients with Alzheimer disease and their caregivers answer questions as a guidance method.

The current study significantly increased the number of participants, allowing researchers to identify several new genetic risk factors for Alzheimer’s disease in African Americans.

The grant will allow for more confidence in risk genes and biological mechanisms that overlap among populations and will also allow for discovery and assessment of additional gene candidates that may be specific to certain populations.

A Q&A from the Mayo Clinic dives into the methods to treat drug-resistant epilepsy that aren't medication based.

Researchers from the Mayo Clinic found a molecular target that can help assess potential treatments for spinocerebellar ataxia type 3, a disease which currently has no cure.

Here's what is coming soon to NeurologyLive.

The amount of neurofilament light may be indicative of neuron injury in the brain.

Neurology News Network for the week ending November 21, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 20, 2020.

Results from a study showed that the higher number of pregnancies, the later the progressive multiple sclerosis onset.

The Consortium of Multiple Sclerosis Centers is seeking poster and platform presentations for the 2021 Annual Meeting, which will take place June 2–5, 2021.